Table 2.
Number of chronic hepatitis B infections and deaths expected with varied vaccination coverage*.
| Vaccination coverage | Without vaccination | Regional target | Maintaining 2012 coverage | 2013 coverage after AEFI |
|---|---|---|---|---|
| Birth dose | 0.0% | 95.0% | 75.6% | 56.0% |
| HepB3 | 0.0% | 95.0% | 96.6% | 59.4% |
| Number of chronic infections | 293,676 | 28,633 | 40,538 | 130,675 |
| Number of deaths | ||||
| Acute | 1181 | 115 | 98 | 515 |
| Liver cirrhosis | 28,126 | 2742 | 3874 | 12,514 |
| Hepatocellular carcinoma | 27,348 | 2666 | 3770 | 12,168 |
| Total deaths | 56,655 | 5524 | 7741 | 25,197 |
*
Assuming HBsAg% in women of reproductive age = 15.8%, HBeAg% in HBsAg positive women = 27.8%, anti-HBc% among 5-year olds = 36.4%, anti-HBc% among 30-year olds = 79.2%, birth dose efficacy = 95% and complete vaccine series efficacy = 95%.